Malin Corporation reported EUR193.2M in Equity Capital and Reserves for its fiscal semester ending in December of 2024.


Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 2.06M 661K Dec/2024
ALKERMES USD 1.62B 113M Jun/2025
Avita Medical AUD 4.5M 19.42M Dec/2024
Dianthus Therapeutics USD 303.08M 49.4M Jun/2025
Eurofins Scientific SE EUR 3.43B 1.91B Jun/2025
Ionis Pharmaceuticals USD 631.72M 156M Jun/2025
IQVIA Holdings USD 5.78B 199M Jun/2025
Lonza CHF 9.33B 23M Dec/2024
Malin Corporation EUR 193.2M 75M Dec/2024
Moderna USD 9.4B 667M Jun/2025
Organon & Co USD 733M 191M Jun/2025
Revvity USD 7.64B 29.74M Mar/2025
Tectonic Therapeutic USD 283.77M 142.99M Jun/2025
Viatris USD 15.57B 79.9M Jun/2025
Xeris Pharmaceuticals USD -19300000 10.32M Jun/2025